LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
Broadstone welcomes Rahul Choudhary as new directorBy News Team10/10/2024 Broadstone appoints Rahul Choudhary to enhance its regulatory analytics framework, marking a key development in their Insurance, Regulatory and Risk division.Choudhary will spearhead initiatives to expand…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
